It is rare when someone takes the time to understand how a field works from each individual player’s perspective. It is also rare that I (almost) fully endorse someone’s conclusions. @alexeyguzey hits the intersection of those two sets in his in depth investigation of biotech.https://twitter.com/alexeyguzey/status/1162017187919478784 …
-
-
What's your case for the bio slowdown? There are se things that right now are kind of stagnant (cost per genome sequences), and others that are getting worse (Eroom's law), but other than that?
- 1 more reply
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
